Andrology & Gynecology: Current ResearchISSN: 2327-4360

Reach Us +44-7480-724769
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, Androl Gynecol Curr Res Vol: 1 Issue: 4

The Significance of Normal Pretreatment Levels of Ca125 (<35 U/Ml) in Epithelial Ovarian Carcinoma

Joseph Menczer*
E.Wolfson Med CTR, Holon, Israel
Corresponding author : Joseph Menczer, MD
E. Wolfson Med CTR, Holon, Israel
Tel: 792 52 3511971; Fax: 792 3 5028812, E-mail: [email protected]
Received: May 10, 2013 Accepted: September 10, 2013 Published: September 18, 2013
Citation: Menczer J (2013) The Significance of Normal Pretreatment Levels of Ca125 (<35 U/Ml) in Epithelial Ovarian Carcinoma. Androl Gynecol: Curr Res 1:4. doi:10.4172/2327-4360.1000108

Abstract

The Significance of Normal Pretreatment Levels of Ca125 (<35 U/Ml) in Epithelial Ovarian Carcinoma

Investigations dealing specifically with the prognostic significance of normal (<35 U/mL) pretreatment serum levels in epithelial ovarian cancer (EOC) patients are scarce. The purpose of the present investigation was to assess the association between normal CA125 levels at diagnosis of EOC with prognostic factors and with outcome.

Keywords: Ovarian cancer; Normal CA125 levels; Prognostic factors; Progression free survival; Overall survival

Track Your Manuscript

Share This Page

Associations